Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,481,700
+$3,677,344 QoQ
Shares Held
133,435
+68.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#177
of 644 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $69,579,172 across 33 Biotechnology names. RPRX ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
50,671 | $12,402,740 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,073 | $10,467,591 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
133,435 | $7,481,700 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,099 | $6,297,130 | |
| 5 | INCY |
Incyte Corp
|
45,186 | $5,122,284 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
47,989 | $3,756,099 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
30,700 | $2,669,365 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
51,900 | $2,030,328 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,481,700 | 133,435 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,804,356 | 79,307 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,689,150 | 69,595 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $561,234 | 15,908 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $573,165 | 15,908 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,044,026 | 65,661 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,459,376 | 57,208 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,291,829 | 81,012 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,136,286 | 81,012 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||